Invention Grant
- Patent Title: Plymorphic forms of deferasirox (ICL670A)
- Patent Title (中): 去甲肾上腺素的多态性（ICL670A）
-
Application No.: US13855132Application Date: 2013-04-02
-
Publication No.: US08946272B2Publication Date: 2015-02-03
- Inventor: Michael Mutz
- Applicant: Michael Mutz
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Gregory Houghton
- Priority: EP06125002 20061129; EP07112795 20070719
- Main IPC: C07D249/08
- IPC: C07D249/08 ; A61K31/4196
Abstract:
The invention relates to crystalline forms of 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid and to its amorphous form, to processes for the preparation thereof, to compositions containing the same and their uses for the manufacture of a medicament for the treatment of the human body.
Public/Granted literature
- US20130267572A1 Plymorphic Forms of Deferasirox (ICL670A) Public/Granted day:2013-10-10
Information query
